Report for Curie C

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (1)

Title : Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53 - Chiorean_2012_Cancer.Chemother.Pharmacol_70_25
Author(s) : Chiorean EG , Sanghani S , Schiel MA , Yu M , Burns M , Tong Y , Hinkle DT , Coleman N , Robb B , LeBlanc J , Clark R , Bufill J , Curie C , Loehrer PJ , Cardenes H
Ref : Cancer Chemother Pharmacol , 70 :25 , 2012
Abstract : Chiorean_2012_Cancer.Chemother.Pharmacol_70_25
ESTHER : Chiorean_2012_Cancer.Chemother.Pharmacol_70_25
PubMedSearch : Chiorean_2012_Cancer.Chemother.Pharmacol_70_25
PubMedID: 22610353